Hill December 18, 2025
Max Rego

Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from the AARP.

The study, published Thursday, found that the out-of-pocket cost of 10 drugs included in the first round of Medicare drug price negotiation will decrease substantially in five states with high enrollment in the program — California, Florida, New York, Pennsylvania and Texas — once negotiated prices go into effect on Jan. 1, 2026.

The drugs, used to treat conditions such as heart disease, diabetes, autoimmune diseases, cancer and chronic kidney disease, are partially covered under Medicare’s Part D prescription drug program. The 2022 Inflation Reduction Act, signed into law by former President Biden, allowed Medicare to...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Insurance, Medicare, Patient / Consumer, Survey / Study, Trends
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable
Medicare Telehealth, Hospital-at-Home Flexibilities In Danger As Partial Government Shutdown Threat Rises
Reengineering ACOs To Make Medicare Competitive
Medicare cuts are destroying independent rural medical practices [PODCAST]
Medicare’s Role in Fighting Chronic Disease

Share Article